Through years of research, physicians discovered fetal skin has a unique ability to heal wounds without scarring. Inspired by this, medical researchers at the University Hospital of Lausanne, Switzerland created a biotechnology process to extract the rich proteins responsible for scarless wound healing from cultured fetal skin cells. A dedicated cell bank was established for developing new skin treatments using a single biopsy of fetal skin. Originally established for wound healing and burn treatments, today this same cell bank also provides a lasting supply of cells for producing NEOCUTIS proprietary skin care ingredient Processed Skin Cell Proteins (PSP®).
PSP® provides the most complete and balanced combination of human growth factors and cytokines currently available.